You haven't been right on this stock....ever. But ok, let's see how you go this time.
"CYP is nearly trading cash on hand value. That's absurd."
No it's not. All the cash on hand is either allocated (refer the latest financials) or to be allocated (i.e. the CR that just happened specifically for the P2 FDA GVHD trial that is in the beginning of the soon to be final stages of starting).
1. CYP are a loooooong way from commercialization. OA has a long way to go and it's very slow, as well as the company nominating that another P3/P4 will be required - 2027/28 before the next P3/P4 is my estimate and opinion. GVHD was nominated as the most likely to commercialise first for CYP, by Ross (and the P2 hasn't started yet). The rest is well beyond those two. 2. More money is needed in general. That's obvious...so why tip in now? 3. More money is needed for the 'front runner' trial, GVHD. That's obvious - hello P3 FDA trial. 4. FujiFilm. Where for art thou? Refer below.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)